Skip to content

A study to compare the effectiveness of Feracrylum Gel and Cetrimide Cream on minor wounds

Phase IV, Multicentre, Observer-Blind, Randomized, Parallel-Group, Comparative Study of Feracrylum Gel and Cetrimide Cream on Minor Traumatic Wounds in Non-Hospitalized Patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/014753
Enrollment
60
Registered
2018-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who have minor traumatic wounds such as cuts, abrasions, lacerations caused by road traffic accidents and other causes

Interventions

Intervention1: Feracrylum gel (1%): The route of administration for Feracrylum 1% Gel is topical. A thin layer of Feracrylum will be applied over entire wound area during initial and subsequent dressi

Sponsors

Themis Medicare Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group between 18 to 60 years 2. Patients who have minor traumatic wounds such as cuts, abrasions, lacerations caused by road traffic accidents and other causes 3. Patients with fresh/untreated wound 4. Patients who provide a signed informed consent to abide by the study requirements

Exclusion criteria

Exclusion criteria: 1. Patients with life threatening injuries 2. Patients with any wound requiring hospitalization 3. Patients with bruises 4. Patients with wounds deeper than subcutaneous tissue 5. Patients with wounds caused by animal bites and burns 6. Patients with pulse > 100/min, Systolic BP 7. Patients with altered sensorium (Glasgow coma scale of 8. Patients with severe bleeding or suspected internal hemorrhage 9. Patients with fractures 10. Patients with suspected internal injury to head, chest, abdomen, pelvis, spine or long bones 11. Patients with history of HIV, cardiac, hepatic, gastrointestinal, renal, pulmonary and skin diseases 12. Women who are lactating or with known pregnancy at the time of screening 13. Known hypersensitivity to any of the ingredients of the test / comparator formulation 14. Simultaneous participation in another clinical study

Design outcomes

Primary

MeasureTime frame
Physician Global Impression (PGI) score on wound condition at Visit 2 (Day 3) based on: 1. Discharge 2. Local Edema 3. Local TendernessTimepoint: Visit 2 (Day 3)

Secondary

MeasureTime frame
1. Change in the bacteriological flora on the wound at Visit 2 compared to Visit 1 2. PGI on wound condition at Visit 3 based on Discharge, Local Edema, and Local Tenderness 3. Ease of dressing change at Visit 2 and 3Timepoint: Visit 1 (Day 0), Visit 2 (Day 3), Visit 3 (Day 7 ±1)

Countries

India

Contacts

Public ContactDr Ashok Swain

Themis Medicare Limited

ashok.swain@themismedicare.com09160255553

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026